Allspring Global Investments Holdings, LLC Verastem, Inc. Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$1.02 - $1.83 $390,861 - $701,252	-383,198 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$1.06 - $2.1 $25,077 - $49,681	-23,658 Reduced 5.81%	383,198 $540,000
Q4 2021 Jan 28, 2022	BUY	$2.05 - $3.2 $834,054 - $1.3 Million	406,856 New	406,856 $834,000

Others Institutions Holding VSTM

# of Institutions

Shares Held

297K

Call Options Held

Put Options Held

Telemetry Investments, L.L.C. New York, NY

225K
Shares

$1.16 Million
0.14% of portfolio
Beaumont Financial Partners, LLC

48K
Shares

$248,160
0.0% of portfolio
Eaton Vance Management Boston, MA

20K
Shares

$103,400
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

2.99K
Shares

$15,432
0.0% of portfolio
Brewin Dolphin Wealth Management LTD Conskleagh, Dublin, L2

1.07K
Shares

$5,552
0.0% of portfolio

View Full List

About Verastem, Inc.

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.09B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

More about VSTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account